Fluoroscopy & Mobile C-Arms Market by Equipment Type (Fixed C Arm, Mini C Arm, Mobile C Arm), Technology (Analog, Digital), Image Intensifier, Price Range, Application, End User - Global Forecast 2025-2032
Description
The Fluoroscopy & Mobile C-Arms Market was valued at USD 2.59 billion in 2024 and is projected to grow to USD 2.76 billion in 2025, with a CAGR of 6.70%, reaching USD 4.36 billion by 2032.
Comprehensive introduction framing fluoroscopy and mobile C-arm technologies as essential procedural imaging solutions reshaping clinical workflows and procurement choices
Fluoroscopy and mobile C-arm technologies occupy a pivotal role in contemporary procedural medicine, enabling image-guided interventions across a wide range of clinical specialties. These systems deliver real-time visualization that supports precision, reduces procedural time, and improves clinical outcomes, particularly in minimally invasive procedures. As clinical protocols evolve and interdisciplinary teams increasingly prioritize image quality, dose optimization, and workflow integration, fluoroscopy solutions are expected to remain central to many care pathways.
Beyond clinical performance, procurement dynamics and capital planning now factor heavily into device adoption decisions. Healthcare providers are balancing the need for high-resolution imaging with considerations around serviceability, total cost of ownership, and interoperability with hospital information systems and picture archiving and communication systems. As a result, manufacturers and health systems are both rethinking product development and acquisition strategies to emphasize modularity, digital connectivity, and lifecycle support. This introduction sets the stage for a deeper exploration of the transformative shifts, regulatory influences, segmentation nuances, regional dynamics, and practical recommendations that follow.
Detailed exploration of the converging technological, clinical, and policy shifts that are rapidly redefining fluoroscopy and mobile C-arm market dynamics and procurement logic
The landscape for fluoroscopy and mobile C-arm technologies is undergoing multiple transformative shifts driven by technological, clinical, and policy forces. Advances in detector technology and image processing algorithms are pushing the boundaries of image clarity while simultaneously enabling dose reduction strategies that respond to heightened awareness of radiation safety. In parallel, the migration from analog to digital platforms is accelerating interoperability and enabling remote diagnostics, predictive maintenance, and improved clinical documentation, which collectively enhance operational efficiency.
Clinically, there is a convergence of use cases as specialties such as cardiology, orthopedics, gastroenterology, and urology increasingly adopt image-guided interventions to reduce invasiveness and enhance precision. This trend is prompting manufacturers to design systems that support multi-specialty use and streamlined reconfiguration. Regulatory and reimbursement environments are also evolving, encouraging investment in safer, more traceable technologies. Finally, the rise of value-based procurement frameworks is prompting health systems to prioritize solutions that demonstrate measurable improvements in throughput, patient safety, and clinician ergonomics, thereby reshaping vendor selection criteria and long-term partnerships.
In-depth analysis of how recent United States tariff adjustments have influenced supply chains, sourcing strategies, and lifecycle procurement decisions for imaging systems
In 2025, changes to United States tariff policy have introduced a new set of considerations for manufacturers, distributors, and health systems that rely on cross-border supply chains for key components and finished imaging systems. Tariff adjustments have affected the pricing calculus for imported components such as flat panel detectors, power electronics, and specialized mechanical assemblies, prompting many manufacturers to re-evaluate sourcing strategies and supplier contracts. These shifts have increased attention on supply chain resilience and onshoring or nearshoring options that can reduce exposure to future tariff volatility.
Consequently, some suppliers have initiated regionalization strategies to mitigate tariff impact, reorganizing manufacturing footprints and distribution networks to maintain competitive margins. At the same time, purchasers are responding to the combined pressures of tariff-related cost variability and broader capital constraints by prioritizing lifecycle service agreements and modular upgrades that extend the value of installed fleets. In effect, tariff changes have catalyzed a broader reassessment of cost, risk, and value across the ecosystem, accelerating strategic moves toward supply diversification and closer alignment between manufacturers and end-user procurement teams.
Comprehensive segmentation insights explaining how equipment types, clinical applications, end-user settings, imaging technologies, detector choices, and pricing tiers shape adoption and differentiation
Key segmentation insights reveal how product design, clinical demand, and procurement behavior intersect across multiple dimensions of the market. Based on equipment type, system selection is shaped by procedural complexity and facility profile, with fixed C-arm solutions emphasizing advanced capabilities for hybrid operating rooms, mini C-arm systems serving localized extremity imaging needs, and mobile C-arm units offering general-purpose flexibility for multi-suite deployment. Based on application, clinical specialties such as cardiology, gastroenterology, orthopedics, and urology impose distinct performance, imaging field-of-view, and workflow requirements that drive differentiation in user interfaces, image acquisition protocols, and accessory ecosystems.
Based on end user, adoption patterns differ across ambulatory surgical centers, diagnostic centers, and hospitals; ambulatory settings prioritize compact footprint and rapid turnover, diagnostic centers emphasize throughput and standardized image quality, while hospitals value versatility and integration with complex care pathways. Based on technology, the migration from analog to digital platforms enables improved image fidelity, easier integration with electronic health records, and enhanced remote service capabilities. Based on image intensifier options, choices between flat panel detectors and traditional image intensifier tubes reflect trade-offs in image resolution, dose efficiency, and capital investment. Based on price range, high-end systems target advanced procedural capabilities and analytics, mid-range solutions balance performance with affordability, and low-end units focus on essential functionality and cost-sensitive environments.
Strategic regional analysis detailing how distinct infrastructure, regulatory environments, and procurement priorities across global territories drive differentiated adoption patterns
Regional dynamics demonstrate differentiated trajectories driven by healthcare infrastructure, regulatory nuances, and capital intensity. The Americas region exhibits concentrated demand in high-acuity hospitals and integrated health systems where investments in advanced imaging support complex cardiovascular and orthopedic procedures; purchasers in this region also emphasize payor-driven value metrics and service partnerships. Europe, Middle East & Africa shows a fragmented landscape with pockets of advanced capability in metropolitan centers alongside regions where cost-sensitive procurement and capacity-building programs shape adoption pathways; regulatory harmonization efforts and public health initiatives influence procurement timelines and technology certification requirements.
Asia-Pacific is characterized by rapid modernization of care infrastructure, expanding ambulatory networks, and strong demand for modular and cost-effective imaging solutions that can scale across diverse facility types. In all regions, local service networks, training programs, and distribution footprints play a decisive role in adoption, as providers seek vendors who can demonstrate fast response times, comprehensive maintenance offerings, and in-region upgrade pathways that protect capital investment over time. Cross-regional partnerships and technology licensing continue to influence product availability and customization options for customers operating in multiple geographies.
Insightful competitive overview highlighting how legacy manufacturers, regional specialists, and software-focused entrants are reshaping product strategies and service models
Competitive dynamics are shaped by a mix of established multinational manufacturers, regional specialists, and emerging technology entrants that focus on software-enabled enhancements and detector innovations. Leading players compete on multiple fronts, including image quality, dose management features, modularity, and service ecosystems that minimize downtime. Strategic partnerships between imaging vendors and component suppliers, as well as alliances with clinical training organizations, are common tactics to accelerate adoption and embed systems into clinical workflows.
Innovation is increasingly driven by software and firmware updates that enhance existing platforms through algorithmic image processing, automated dose tracking, and remote diagnostic capabilities. At the same time, some companies are differentiating through financing and service models that reduce upfront barriers for customers, offering subscription-based maintenance or bundled upgrade pathways. New entrants often concentrate on niche segments-such as compact detectors for outpatient settings or specialized interfaces for interventional suites-forcing incumbents to refine product roadmaps and commercial approaches. Overall, the competitive environment rewards agility in product development, depth of service capabilities, and demonstrable clinical partnerships that validate system performance in real-world settings.
Pragmatic and forward-looking recommendations for industry leaders to balance modular innovation, dose management, service expansion, and flexible commercial models for growth
Industry leaders should adopt a proactive posture that balances technological innovation with pragmatic commercialization strategies. First, prioritize modular product architectures that allow customers to scale system capabilities through software upgrades and hardware add-ons, thereby protecting their capital investments and enabling easier cross-selling into existing installed bases. This approach supports longer service relationships and creates recurring revenue opportunities while meeting diverse clinical requirements.
Second, invest in detector and image processing advancements that demonstrably reduce radiation dose while preserving or improving image clarity for specific specialties like cardiology and orthopedics; these clinical-value differentiators will resonate with procurement teams focused on patient safety and regulatory compliance. Third, expand regional service footprints and training programs to reduce customer friction and strengthen long-term retention, with localized parts inventories and remote diagnostic capabilities as priority enablers. Fourth, explore flexible commercial models that combine capital financing, outcome-based service agreements, and bundled maintenance to lower adoption barriers for cost-sensitive buyers. Finally, cultivate clinical partnerships and real-world evidence initiatives that quantify workflow improvements and clinical outcomes, thereby creating robust case studies that support market access and reimbursement discussions.
Transparent and reproducible research methodology combining primary stakeholder interviews, secondary technical review, and cross-validated expert panel assessment for robust insights
The research methodology integrates a structured, multi-source approach to ensure robust, triangulated insights. Primary research included confidential interviews with clinicians, procurement professionals, biomedical engineers, and senior executives responsible for imaging strategy, capturing qualitative perspectives on clinical needs, decision criteria, and service expectations. Secondary research synthesized peer-reviewed literature, regulatory guidance, product technical specifications, and publicly available procurement documents to contextualize primary inputs and validate technical claims.
Data validation leveraged cross-referencing techniques and expert panel reviews to reconcile any inconsistencies and to test hypotheses about segmentation and regional dynamics. The methodology also incorporated scenario analysis to assess how external drivers-such as policy shifts, tariff changes, and technology maturation-might influence strategic choices. Throughout, emphasis was placed on reproducibility and transparency, with clear documentation of sources, interview protocols, and assumptions to support interpretability and future replication by clients seeking deeper dive analyses.
Concluding synthesis highlighting the pathways for differentiation and sustainable adoption through technology, service expansion, and clinician-aligned strategies
The collective analysis underscores that fluoroscopy and mobile C-arm technologies remain central to the modernization of procedural medicine, with momentum driven by detector advancements, digital integration, and an expanding set of clinical use cases. Stakeholders across the ecosystem are recalibrating priorities: providers seek systems that deliver superior image quality and dose efficiency while offering flexible service and financing terms, and suppliers are innovating through modular designs and software-enabled value additions to meet those needs.
Looking ahead, organizations that align product roadmaps with clinician-centric workflows, invest in regional service capability, and deploy flexible commercial models will be best positioned to capture opportunities and mitigate risks associated with policy and supply chain shifts. In sum, the sector offers clear pathways for competitive differentiation through focused investments in technology, service, and clinical partnership strategies that address the immediate operational pressures of health systems while enabling sustainable growth.
Note: PDF & Excel + Online Access - 1 Year
Comprehensive introduction framing fluoroscopy and mobile C-arm technologies as essential procedural imaging solutions reshaping clinical workflows and procurement choices
Fluoroscopy and mobile C-arm technologies occupy a pivotal role in contemporary procedural medicine, enabling image-guided interventions across a wide range of clinical specialties. These systems deliver real-time visualization that supports precision, reduces procedural time, and improves clinical outcomes, particularly in minimally invasive procedures. As clinical protocols evolve and interdisciplinary teams increasingly prioritize image quality, dose optimization, and workflow integration, fluoroscopy solutions are expected to remain central to many care pathways.
Beyond clinical performance, procurement dynamics and capital planning now factor heavily into device adoption decisions. Healthcare providers are balancing the need for high-resolution imaging with considerations around serviceability, total cost of ownership, and interoperability with hospital information systems and picture archiving and communication systems. As a result, manufacturers and health systems are both rethinking product development and acquisition strategies to emphasize modularity, digital connectivity, and lifecycle support. This introduction sets the stage for a deeper exploration of the transformative shifts, regulatory influences, segmentation nuances, regional dynamics, and practical recommendations that follow.
Detailed exploration of the converging technological, clinical, and policy shifts that are rapidly redefining fluoroscopy and mobile C-arm market dynamics and procurement logic
The landscape for fluoroscopy and mobile C-arm technologies is undergoing multiple transformative shifts driven by technological, clinical, and policy forces. Advances in detector technology and image processing algorithms are pushing the boundaries of image clarity while simultaneously enabling dose reduction strategies that respond to heightened awareness of radiation safety. In parallel, the migration from analog to digital platforms is accelerating interoperability and enabling remote diagnostics, predictive maintenance, and improved clinical documentation, which collectively enhance operational efficiency.
Clinically, there is a convergence of use cases as specialties such as cardiology, orthopedics, gastroenterology, and urology increasingly adopt image-guided interventions to reduce invasiveness and enhance precision. This trend is prompting manufacturers to design systems that support multi-specialty use and streamlined reconfiguration. Regulatory and reimbursement environments are also evolving, encouraging investment in safer, more traceable technologies. Finally, the rise of value-based procurement frameworks is prompting health systems to prioritize solutions that demonstrate measurable improvements in throughput, patient safety, and clinician ergonomics, thereby reshaping vendor selection criteria and long-term partnerships.
In-depth analysis of how recent United States tariff adjustments have influenced supply chains, sourcing strategies, and lifecycle procurement decisions for imaging systems
In 2025, changes to United States tariff policy have introduced a new set of considerations for manufacturers, distributors, and health systems that rely on cross-border supply chains for key components and finished imaging systems. Tariff adjustments have affected the pricing calculus for imported components such as flat panel detectors, power electronics, and specialized mechanical assemblies, prompting many manufacturers to re-evaluate sourcing strategies and supplier contracts. These shifts have increased attention on supply chain resilience and onshoring or nearshoring options that can reduce exposure to future tariff volatility.
Consequently, some suppliers have initiated regionalization strategies to mitigate tariff impact, reorganizing manufacturing footprints and distribution networks to maintain competitive margins. At the same time, purchasers are responding to the combined pressures of tariff-related cost variability and broader capital constraints by prioritizing lifecycle service agreements and modular upgrades that extend the value of installed fleets. In effect, tariff changes have catalyzed a broader reassessment of cost, risk, and value across the ecosystem, accelerating strategic moves toward supply diversification and closer alignment between manufacturers and end-user procurement teams.
Comprehensive segmentation insights explaining how equipment types, clinical applications, end-user settings, imaging technologies, detector choices, and pricing tiers shape adoption and differentiation
Key segmentation insights reveal how product design, clinical demand, and procurement behavior intersect across multiple dimensions of the market. Based on equipment type, system selection is shaped by procedural complexity and facility profile, with fixed C-arm solutions emphasizing advanced capabilities for hybrid operating rooms, mini C-arm systems serving localized extremity imaging needs, and mobile C-arm units offering general-purpose flexibility for multi-suite deployment. Based on application, clinical specialties such as cardiology, gastroenterology, orthopedics, and urology impose distinct performance, imaging field-of-view, and workflow requirements that drive differentiation in user interfaces, image acquisition protocols, and accessory ecosystems.
Based on end user, adoption patterns differ across ambulatory surgical centers, diagnostic centers, and hospitals; ambulatory settings prioritize compact footprint and rapid turnover, diagnostic centers emphasize throughput and standardized image quality, while hospitals value versatility and integration with complex care pathways. Based on technology, the migration from analog to digital platforms enables improved image fidelity, easier integration with electronic health records, and enhanced remote service capabilities. Based on image intensifier options, choices between flat panel detectors and traditional image intensifier tubes reflect trade-offs in image resolution, dose efficiency, and capital investment. Based on price range, high-end systems target advanced procedural capabilities and analytics, mid-range solutions balance performance with affordability, and low-end units focus on essential functionality and cost-sensitive environments.
Strategic regional analysis detailing how distinct infrastructure, regulatory environments, and procurement priorities across global territories drive differentiated adoption patterns
Regional dynamics demonstrate differentiated trajectories driven by healthcare infrastructure, regulatory nuances, and capital intensity. The Americas region exhibits concentrated demand in high-acuity hospitals and integrated health systems where investments in advanced imaging support complex cardiovascular and orthopedic procedures; purchasers in this region also emphasize payor-driven value metrics and service partnerships. Europe, Middle East & Africa shows a fragmented landscape with pockets of advanced capability in metropolitan centers alongside regions where cost-sensitive procurement and capacity-building programs shape adoption pathways; regulatory harmonization efforts and public health initiatives influence procurement timelines and technology certification requirements.
Asia-Pacific is characterized by rapid modernization of care infrastructure, expanding ambulatory networks, and strong demand for modular and cost-effective imaging solutions that can scale across diverse facility types. In all regions, local service networks, training programs, and distribution footprints play a decisive role in adoption, as providers seek vendors who can demonstrate fast response times, comprehensive maintenance offerings, and in-region upgrade pathways that protect capital investment over time. Cross-regional partnerships and technology licensing continue to influence product availability and customization options for customers operating in multiple geographies.
Insightful competitive overview highlighting how legacy manufacturers, regional specialists, and software-focused entrants are reshaping product strategies and service models
Competitive dynamics are shaped by a mix of established multinational manufacturers, regional specialists, and emerging technology entrants that focus on software-enabled enhancements and detector innovations. Leading players compete on multiple fronts, including image quality, dose management features, modularity, and service ecosystems that minimize downtime. Strategic partnerships between imaging vendors and component suppliers, as well as alliances with clinical training organizations, are common tactics to accelerate adoption and embed systems into clinical workflows.
Innovation is increasingly driven by software and firmware updates that enhance existing platforms through algorithmic image processing, automated dose tracking, and remote diagnostic capabilities. At the same time, some companies are differentiating through financing and service models that reduce upfront barriers for customers, offering subscription-based maintenance or bundled upgrade pathways. New entrants often concentrate on niche segments-such as compact detectors for outpatient settings or specialized interfaces for interventional suites-forcing incumbents to refine product roadmaps and commercial approaches. Overall, the competitive environment rewards agility in product development, depth of service capabilities, and demonstrable clinical partnerships that validate system performance in real-world settings.
Pragmatic and forward-looking recommendations for industry leaders to balance modular innovation, dose management, service expansion, and flexible commercial models for growth
Industry leaders should adopt a proactive posture that balances technological innovation with pragmatic commercialization strategies. First, prioritize modular product architectures that allow customers to scale system capabilities through software upgrades and hardware add-ons, thereby protecting their capital investments and enabling easier cross-selling into existing installed bases. This approach supports longer service relationships and creates recurring revenue opportunities while meeting diverse clinical requirements.
Second, invest in detector and image processing advancements that demonstrably reduce radiation dose while preserving or improving image clarity for specific specialties like cardiology and orthopedics; these clinical-value differentiators will resonate with procurement teams focused on patient safety and regulatory compliance. Third, expand regional service footprints and training programs to reduce customer friction and strengthen long-term retention, with localized parts inventories and remote diagnostic capabilities as priority enablers. Fourth, explore flexible commercial models that combine capital financing, outcome-based service agreements, and bundled maintenance to lower adoption barriers for cost-sensitive buyers. Finally, cultivate clinical partnerships and real-world evidence initiatives that quantify workflow improvements and clinical outcomes, thereby creating robust case studies that support market access and reimbursement discussions.
Transparent and reproducible research methodology combining primary stakeholder interviews, secondary technical review, and cross-validated expert panel assessment for robust insights
The research methodology integrates a structured, multi-source approach to ensure robust, triangulated insights. Primary research included confidential interviews with clinicians, procurement professionals, biomedical engineers, and senior executives responsible for imaging strategy, capturing qualitative perspectives on clinical needs, decision criteria, and service expectations. Secondary research synthesized peer-reviewed literature, regulatory guidance, product technical specifications, and publicly available procurement documents to contextualize primary inputs and validate technical claims.
Data validation leveraged cross-referencing techniques and expert panel reviews to reconcile any inconsistencies and to test hypotheses about segmentation and regional dynamics. The methodology also incorporated scenario analysis to assess how external drivers-such as policy shifts, tariff changes, and technology maturation-might influence strategic choices. Throughout, emphasis was placed on reproducibility and transparency, with clear documentation of sources, interview protocols, and assumptions to support interpretability and future replication by clients seeking deeper dive analyses.
Concluding synthesis highlighting the pathways for differentiation and sustainable adoption through technology, service expansion, and clinician-aligned strategies
The collective analysis underscores that fluoroscopy and mobile C-arm technologies remain central to the modernization of procedural medicine, with momentum driven by detector advancements, digital integration, and an expanding set of clinical use cases. Stakeholders across the ecosystem are recalibrating priorities: providers seek systems that deliver superior image quality and dose efficiency while offering flexible service and financing terms, and suppliers are innovating through modular designs and software-enabled value additions to meet those needs.
Looking ahead, organizations that align product roadmaps with clinician-centric workflows, invest in regional service capability, and deploy flexible commercial models will be best positioned to capture opportunities and mitigate risks associated with policy and supply chain shifts. In sum, the sector offers clear pathways for competitive differentiation through focused investments in technology, service, and clinical partnership strategies that address the immediate operational pressures of health systems while enabling sustainable growth.
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
194 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Integration of artificial intelligence algorithms for real-time image enhancement in mobile C-arms
- 5.2. Growing adoption of low-dose radiation protocols to minimize patient exposure during fluoroscopy imaging
- 5.3. Emergence of portable, battery-operated C-arm systems enabling point-of-care imaging in remote settings
- 5.4. Implementation of cloud-based image storage and sharing platforms for seamless fluoroscopy workflow
- 5.5. Development of high-resolution flat-panel detectors to improve diagnostic accuracy in C-arm procedures
- 5.6. Rising demand for hybrid operating rooms integrating advanced fluoroscopy and surgical navigation systems
- 5.7. Increasing regulatory emphasis on cybersecurity for connected C-arm units in clinical environments
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Fluoroscopy & Mobile C-Arms Market, by Equipment Type
- 8.1. Fixed C Arm
- 8.2. Mini C Arm
- 8.3. Mobile C Arm
- 9. Fluoroscopy & Mobile C-Arms Market, by Technology
- 9.1. Analog
- 9.2. Digital
- 10. Fluoroscopy & Mobile C-Arms Market, by Image Intensifier
- 10.1. Flat Panel Detector
- 10.2. Image Intensifier Tube
- 11. Fluoroscopy & Mobile C-Arms Market, by Price Range
- 11.1. High End
- 11.2. Low End
- 11.3. Mid Range
- 12. Fluoroscopy & Mobile C-Arms Market, by Application
- 12.1. Cardiology
- 12.2. Gastroenterology
- 12.3. Orthopedics
- 12.4. Urology
- 13. Fluoroscopy & Mobile C-Arms Market, by End User
- 13.1. Ambulatory Surgical Centers
- 13.2. Diagnostic Centers
- 13.3. Hospitals
- 14. Fluoroscopy & Mobile C-Arms Market, by Region
- 14.1. Americas
- 14.1.1. North America
- 14.1.2. Latin America
- 14.2. Europe, Middle East & Africa
- 14.2.1. Europe
- 14.2.2. Middle East
- 14.2.3. Africa
- 14.3. Asia-Pacific
- 15. Fluoroscopy & Mobile C-Arms Market, by Group
- 15.1. ASEAN
- 15.2. GCC
- 15.3. European Union
- 15.4. BRICS
- 15.5. G7
- 15.6. NATO
- 16. Fluoroscopy & Mobile C-Arms Market, by Country
- 16.1. United States
- 16.2. Canada
- 16.3. Mexico
- 16.4. Brazil
- 16.5. United Kingdom
- 16.6. Germany
- 16.7. France
- 16.8. Russia
- 16.9. Italy
- 16.10. Spain
- 16.11. China
- 16.12. India
- 16.13. Japan
- 16.14. Australia
- 16.15. South Korea
- 17. Competitive Landscape
- 17.1. Market Share Analysis, 2024
- 17.2. FPNV Positioning Matrix, 2024
- 17.3. Competitive Analysis
- 17.3.1. Analogic Corporation
- 17.3.2. Canon Medical Systems Corporation
- 17.3.3. Esaote S.p.A
- 17.3.4. General Electric Company
- 17.3.5. Hologic, Inc.
- 17.3.6. Koninklijke Philips N.V.
- 17.3.7. Omega Medical Imaging LLC
- 17.3.8. OrthoScan, Inc
- 17.3.9. Recorders & Medicare Systems Pvt Ltd
- 17.3.10. Shimadzu Corporation
- 17.3.11. Siemens Healthcare
- 17.3.12. Siemens Healthineers AG
- 17.3.13. SternMed GmBH
- 17.3.14. Toshiba Corporation
- 17.3.15. Turner Imaging System
- 17.3.16. Varian Medical Systems Inc.
- 17.3.17. Villa SistemiMedicali Spa
- 17.3.18. Ziehm Imaging GmbH
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
